BIOA · trading date Oct 9, 2026 · previous close $6.21 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$9.00M
Net income
-$80.61M
Total assets
$294.89M
Total liabilities
$22.84M
Stockholders' equity
$272.05M
Cash & equivalents
$188.89M
Operating income
-$92.78M
Operating cash flow
-$81.63M
Capital expenditures
$719.0K
Fiscal year 2025, via 10-K filed 2026-03-24.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-1,031.5%
Net margin
-896.1%
Free cash flow
-$82.35M
Free cash flow margin
-915.5%
Liabilities / assets
7.7%
Equity / assets
92.3%
CapEx / revenue
8.0%
Operating cash flow / net income
1.01×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Emeryville, CA 94608
5885 HOLLIS STREET
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:18 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.